OTX-2002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OTX-2002, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene [Phase 1, Phase 2]